TB-500 5mg

TB-500 is a thymosin beta-4–derived research peptide used in controlled in-vitro studies of cell migration, cytoskeletal dynamics, and extracellular-matrix signalling under non-clinical laboratory conditions.

TB-500 (Thymosin Beta-4 Fragment)

This peptide is selected in model systems to explore pathways related to actin modulation, tissue biology, and assay readouts for cell motility and matrix interaction. All investigations are performed in laboratory settings only.
For laboratory research only. Not for human use.

TB-500 Key features

• Thymosin beta-4 fragment for in-vitro studies of cell migration and ECM-related pathways.
• Supplied as a lyophilised solid for stability and straightforward storage.
• Unit size: 5 mg per vial.
• Each batch released only after stringent quality checks.

Specifications

• Product name: TB-500
• Synonyms: Thymosin beta-4 fragment; TB4 fragment peptide
• Class: Peptide fragment (research use)
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Identity and exact properties may vary with salt/counter-ion and hydration state.

Handling & storage

1. Storage (dry): Keep vials protected from light and moisture.
2. Reconstitution: Bring vial and diluent to room temperature. Reconstitute with
   Bacteriostatic Water 10 ml. Swirl gently — do not vortex.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and tissue/ECM research companions such as
GHK-Cu 50 mg and
SS-31 10 mg.

About TB-500 in research

Researchers use TB-500 to interrogate assay readouts associated with cytoskeletal organisation, cell migration, and extracellular-matrix interactions in model systems. These studies focus on molecular mechanisms and pathway mapping, not clinical use.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.